Mary Egidy
Psychiatric/Mental Health · Lawrence, KSNPI 1841392206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations.
Across 189 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$752
- Supernus Pharmaceuticals, Inc.$346
- Tris Pharma Inc$312
- Sunovion Pharmaceuticals Inc.$305
- Neos Therapeutics, LP$287
- plus $2K from 13 others
What the payments were for
- Food & beverage$4,46599%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $1,021 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $752 |
| Supernus Pharmaceuticals, Inc. | 13 | $346 |
| Tris Pharma Inc | 6 | $312 |
| Sunovion Pharmaceuticals Inc. | 21 | $305 |
| Neos Therapeutics, LP | 21 | $287 |
| Corium, LLC | 11 | $271 |
| Johnson & Johnson | 5 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $215 |
| Jazz Pharmaceuticals Inc. | 8 | $153 |
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $114 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Lundbeck LLC | 5 | $80 |
| Alkermes, Inc. | 2 | $55 |
| Ironshore Pharmaceuticals Inc. | 3 | $49 |
| Noven Therapeutics, LLC | 2 | $33 |
| Adlon Therapeutics L.p. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$583
- Dyanavel XR$243
- Quillivant$243
- Quillichew ER$243
- SPRAVATO$135
- CAPLYTA$122
- Azstarys$116
- COBENFY$114
How this compares
$4,526 in reported general payments places this provider in the 85th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wellbutrin SrBupropion Hcl | 12 | $5,574 |
| Atomoxetine Hcl | 16 | $3,499 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $530 |
| Duloxetine Hcl | 21 | $337 |
| Lamotrigine | 41 | $336 |
| Quetiapine Fumarate | 12 | $180 |
| Clonazepam | 31 | $153 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $149 |
| Gabapentin | 11 | $146 |
| Eszopiclone | 20 | $136 |
| Alprazolam | 19 | $56 |
| Trazodone Hcl | 15 | $12 |
| Fluoxetine Hcl | 14 | $1 |
| Clonidine Hcl | 11 | $0 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Lawrence
- Adrian CadeLawrence$5K
- Eric ThomasonPittsburg$333K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.